76
Views
0
CrossRef citations to date
0
Altmetric
COMMENTARY

The Butterfly Flies - Practice Changing Results of PAPILLON, First Line Chemotherapy and Amivantamab for the Treatment of NSCLC Patients with EGFR Exon 20 Insertions

& ORCID Icon
Pages 49-54 | Received 13 Dec 2023, Accepted 23 Mar 2024, Published online: 23 Apr 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.